Previous 10 | Next 10 |
2024-05-23 06:49:51 ET Summary Nvidia's Q1 results and guidance exceed expectations, leading to an increase in stock price and announcement of a 10-1 stock split. Live Nation Entertainment shares drop as the DOJ plans to announce an antitrust lawsuit against the company. Vacci...
2024-05-22 17:43:22 ET Several vaccine makers closed Wednesday up with double-digit percentage gains amid a report of the first avian flu case in a human in Australia and a second case in the U.S.... Read the full article on Seeking Alpha For further details see: Moderna...
2024-05-22 14:00:26 ET More on BioNTech, Moderna, etc. Pfizer: Offsetting The LOE Cliff Crisis With 6 New Potential Blockbuster Drugs Aggressive Strides Forward For Moderna's Cancer Vaccine Pfizer Stock: Rebound Has Started (Technical Analysis) Pfizer launchi...
CureVac N.V. (NASDAQ: CVAC) is one of today's top gainers. The company's shares have moved 23.1% on the day to $4.05. CureVac N.V., a clinical-stage biopharmaceutical company, focuses on developing various transformative medicines based on messenger ribonucleic acid (mRNA). It is developing pr...
2024-05-22 11:07:09 ET More on CureVac BV, GSK, etc. GSK plc (GSK) Q1 2024 Earnings Call Transcript CureVac N.V. (CVAC) Q4 2023 Earnings Call Transcript CureVac N.V. 2023 Q4 - Results - Earnings Call Presentation GSK succeeds in late-stage trials for asthma c...
2024-05-22 10:00:31 ET More on etc. Replimune: Continuing To Justify The Bear Thesis (For Now) Gold At $3,000 Is The Wrong Way To Think About The Precious Metal Best Buy: Poised For Growth Amid E-Commerce Threat Nvidia’s upcoming earnings has investors...
2024-05-19 08:02:00 ET Retailers will also be in the spotlight, with updates anticipated from Target ( NYSE: TGT ), Lowe's ( LOW ), Macy’s ( M ), Ross Stores ( ROST ), TJX Companies ( TJX ), Ralph Lauren ( RL ) and Urban Outfitters ( URBN ).... R...
2024-05-15 13:54:04 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips CureVac (NASDAQ: CVAC ) just reported results for the fourth quarter of 2023. CureVac reported earnings per share of -41 cents. This was below the analyst estimate for EPS...
2024-05-10 06:36:00 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips There are several stocks to sell now that are clinging to life support. These companies have been diluting their shares and burning cash at an alarming rate, making a successful comeback an inc...
2024-04-24 15:12:02 ET CureVac N.V. (CVAC) Q4 2023 Earnings Conference Call April 24, 2024 09:00 AM ET Company Participants Sarah Fakih - Vice President of Corporate Communications & Investor Relations Alexander Zehnder - Chief Executive Officer Myriam Mendil...
News, Short Squeeze, Breakout and More Instantly...
New trial date for U.S. patent litigation set for March 3, 2025, following settlement with Acuitas Therapeutics First instance decision on validity of EP 3 708 668 B1 (split poly-A tail technology) scheduled for March 25, 2025, by European Patent Office in the context of the German patent ...
GSK acquires full rights to develop, manufacture and commercialize globally mRNA candidate vaccines for influenza and COVID-19, including combinations CureVac receives €400 million upfront and up to an additional €1.05 billion in development, regulatory and sales milestone pa...
Strategic restructuring includes a workforce reduction of approximately 30%, re-focusing on research, development, and innovation to create leaner and more agile organization Prioritization of high-value opportunities in oncology and other selected diseases, leveraging proprietary mRNA tec...